💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Gilead Sciences, Inc. (GILD)
« Back to company indexGILD Chatter Timeline
Stock Ticker for GILD
Most Active Tweeters for GILD
| User | Tweets |
|---|---|
| @MinteractApp | 10 |
| @StockDripSplash | 10 |
| @Gambiste1 | 10 |
| @HealthcareBeat | 9 |
| @urtrading | 8 |
Recent Tweets for GILD
 |
@SatoshiAlien $GILD if we can get a move through 78 on some volume we're looking at an 80 roll. 7:06pm |
 |
@newsfilterio Gilead Sciences Shares Bought by GHP Investment Advisors $GILD https://t.co/h4BA8fH7nM 4:06pm |
 |
@bbnsnews Gilead Sciences $GILD Lifted to “Outperform” at SVB Leerink https://t.co/L80OZl3iHY 1:06pm |
 |
@MinteractApp #Options Flow Grid Update $GILD #OptionsTrading #Gilead Sciences Shares?1.02% to $76.75 #OptionsFlow #stocks #stock… https://t.co/u7ctA0GDVx 1:06pm |
 |
@fezziwig2019 @AHimar33 $GILD Re-Meh-Desivir has underwhelming results early, moderate, and late -Better than nothing except for… https://t.co/4lW8n9bhyE 1:06pm |
 |
@WeekHerald Gilead Sciences’ $GILD Buy Rating Reiterated at Royal Bank of Canada https://t.co/w2Qu31YFGz 12:06pm |
 |
@KenFaulkenberry $GILD Gilead Sciences Intrinsic Value Analysis: https://t.co/Uca21OUevF #dividends #healthcare #biotechnology… https://t.co/PB7jnylYp2 12:06pm |
 |
@AmericanBanking Gilead Sciences, Inc. $GILD Expected to Post Earnings of $1.57 Per Share https://t.co/PNEwbMW7Hs #stocks 11:06am |
 |
@TranscriptDaily Gilead Sciences, Inc. $GILD Expected to Post Earnings of $1.57 Per Share https://t.co/og0MDYUVG5 11:06am |
 |
@HealthcareBeat NorthCoast Asset Management Acquires New Position in Gilead Sciences $GILD https://t.co/yyKA6Vr6Ct 11:06am |
|
@newsfilterio NorthCoast Asset Management Acquires New Position in Gilead Sciences $GILD https://t.co/jhPsP5o7lK 11:06am |
 |
@peterbachmd TY @megtirrell @CNBC. As I noted, we shld not assume $GILD needs to get a huge price for their modestly effective t… https://t.co/wEsTbIXfGu 9:06am |
|
@HealthcareBeat Gilead Sciences’ “Hold” Rating Reiterated at Maxim Group $GILD https://t.co/1eUi3n2UT1 8:06am |
|
@newsfilterio Gilead Sciences’ “Hold” Rating Reiterated at Maxim Group $GILD https://t.co/T0dsqaK9qW 8:06am |
 |
@stocknewstimes Gilead Sciences’ $GILD “Hold” Rating Reiterated at Maxim Group https://t.co/fgyetyMRWY 8:06am |
 |
@MarketFollows Finding a fair profit for Gilead on coronavirus-fighting drug, Remdesivir $GILD https://t.co/3UJK8WlcSR $SPY June 5th 2020, 8:06pm |
|
@MinteractApp $GILD Gilead Sciences #Options Power, #Options #maxpain Chart, Open Interest Chart Update #OptionsTrading… https://t.co/ZZnnWjynwp June 5th 2020, 8:06pm |
 |
@OlympiaReport Gilead Sciences $GILD Earns “Hold” Rating from Maxim Group https://t.co/nm5JkTP50B June 5th 2020, 7:06pm |
|
@OlympiaReport Gilead Sciences $GILD Rating Reiterated by Needham & Company LLC https://t.co/z4lxs6FB5k June 5th 2020, 7:06pm |
|
@newsfilterio Pharming Group Might Have An Effective COVID-19 Treatment Ready For Use $GILD $PHGUF #coronavirus #COVID2019 https://t.co/5vlq6EEpSX June 5th 2020, 7:06pm |
 |
@Piddybul RT @Bacosan1979: Gilead tackles a big PhIII program for blockbuster hopeful filgotinib $GLPG $GILD #Filgotinib - https://t.co/ooHqgpfacH June 5th 2020, 6:06pm |
 |
@urtrading $GILD ?? & $GOOGL ?? https://t.co/lbmaBsbVTz June 5th 2020, 6:06pm |
 |
@Briefingcom $GILD: Gilead Sciences and Galapagos NV (GLPG) announce new analyses from trials evaluating filgotinib in adults... https://t.co/qVJJi2k3eD June 5th 2020, 6:06pm |
 |
@Kyle__wdennis Excellent on $GILD Nathan! June 5th 2020, 6:06pm |
 |
@equity_newswire $GILD New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of Filgotinib in Psoriatic Arthritis https://t.co/dPqoOoD4NV June 5th 2020, 5:06pm |
 |
@permabear_uk $GILD settled -1.0% to $76.75. 200dma remains a valid target. M/t bullish to giant psy'100. https://t.co/HTeiSjuPWb June 5th 2020, 5:06pm |
 |
@katcar54 @martingeddes I guess he wasn’t being paid by Gilead $GILD back in 2013. Funny how money changes one’s research outcomes. #LancetGate June 5th 2020, 4:06pm |
 |
@InvestorPlace Investing During Coronavirus: Buy Gilead Stock on New Remdesivir Pricing Estimates $GILD https://t.co/KRt5km4def June 5th 2020, 4:06pm |
 |
@manzoorsohail Is #remdesivir a Disappointment? @themotleyfool #stocks $GILD https://t.co/aR6f3WRJIM June 5th 2020, 4:06pm |
|
@manzoorsohail Is Remdesivir a Disappointment? @themotleyfool #stocks $GILD https://t.co/aR6f3WRJIM June 5th 2020, 4:06pm |
 |
@HNWequities RT @otcdynamics: $GILD NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS https… June 5th 2020, 4:06pm |
 |
@otcdynamics $GILD NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS https://t.co/xHGvm4QiQ8 June 5th 2020, 4:06pm |
 |
@kevinjaybe RT @biotechradar_eu: $GLPG $GILD NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN P… June 5th 2020, 4:06pm |
 |
@biotechradar_eu $GLPG $GILD NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN… https://t.co/9gN4p4Y9VN June 5th 2020, 4:06pm |
 |
@FlashAlert_me $GILD [15s. delayed]: Issued Press Release on June 05, 16:01:00: New Analyses of Phase 2 EQUATOR Clinical Program S… https://t.co/ss9HkW6xBz June 5th 2020, 4:06pm |
 |
@portefeuillefun $GLPG $GILD. New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of #Filgotinib in Psoriatic… https://t.co/48kDY3NBDi June 5th 2020, 4:06pm |
|
@otcdynamics $GILD New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of Filgotinib in Psoriatic Arthritis https://t.co/72tIAvAfGj June 5th 2020, 4:06pm |
 |
@alexserri1 $GILD - New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of Filgotinib in Psoriatic https://t.co/xeADA03t9f June 5th 2020, 4:06pm |
|
@FlashAlert_me $GILD [15s. delayed]: Issued Press Release on June 05, 16:01:00: NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PR… https://t.co/jOsfLBWY7y June 5th 2020, 4:06pm |
 |
@OfficialHemp $GILD FDA granted Gilead’s #remdesivir emergency authorization for #COVID19 COVID-19 treatment… https://t.co/YwgPhQsaNT June 5th 2020, 3:06pm |
|
@OfficialHemp $GILD FDA Approved Medicine for #COVID19 https://t.co/XhfMFm9ygS June 5th 2020, 3:06pm |
|
@OfficialHemp $GILD the next $JNJ June 5th 2020, 3:06pm |
|
@OfficialHemp $GILD June 5th 2020, 3:06pm |
 |
@davidmaris @megtirrell @CNBC I think the Street assumptuons around $GILD pricing are wrong. Dont forget the largest cutomer... https://t.co/GwByvHJFLV June 5th 2020, 3:06pm |
 |
@OfficialMining RT @OfficialMining: $GILD next leg $84.77 June 5th 2020, 3:06pm |
|
@OfficialMining $GILD next leg $84.77 June 5th 2020, 2:06pm |
 |
@MMeatloaf7 $gild daily. ? setup https://t.co/wDUbPo7Gag June 5th 2020, 2:06pm |
|
@MMeatloaf7 $gild weekly. Trying to close week with green hammer/inside week at lower channel setup for an explosive up move w… https://t.co/OOL6ZT6bwf June 5th 2020, 2:06pm |
 |
@BakkenShale $GILD heavy buying pressure coming in June 5th 2020, 1:06pm |
|
@BakkenShale Is $GILD only FDA approved #COVID19 medicine?? https://t.co/umDdYDoD6y June 5th 2020, 1:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities